Apogee Therapeutics, Inc. (APGE) Stock Analysis
DELISTED
What happened to Apogee Therapeutics, Inc. (APGE) stock?
Apogee Therapeutics, Inc. (APGE) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $8.36B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Apogee Therapeutics, Inc. (APGE). Apogee Therapeutics, Inc. is a biotechnology company focused on developing biologics for inflammatory and immunology indications. Their primary drug candidates include APG777 for atopic dermatitis and APG808 for chronic obstructive pulmonary disease.
Last analyzed: May 10, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Apogee Therapeutics, Inc. (APGE) Healthcare & Pipeline Overview
More about this archive record
Can I still buy APGE shares?
No. APGE stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for APGE elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before APGE stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Apogee Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.